Antidiarrheal activity of α-Terpineol (cas 8000-41-7) in mice
-
Add time:07/15/2019 Source:sciencedirect.com
Diarrhea is one of the leading causes of infant death in the world accounting for high child mortality rate. It is also present in different pathophysiologies related to several etiological agents. The aim of this study is to investigate the antidiarrheal effect of α –Terpineol (α-TPN) in different diarrhea models in rodents. The antidiarrheal effect of α-TPN in the treatment of acute diarrhea and enteropooling induced by castor oil or PGE2 in Swiss mice pretreated orally with saline (NaCl 0.9%), Loperamide (5 mg/kg) and α-TPN (6.25, 12.5, 25 and 50 mg/kg) was analyzed. Additionally, parameters of severity, total weight of faeces and post-treatment for 4 h were evaluated. Modulation of the opioid and cholinergic pathways was performed and intestinal transit model using activated charcoal as marker was also used. The effect of α-TPN on secretory diarrhea was investigated using the model of fluid secretion in intestinal loops isolated from cholera toxin-treated mice. α-TPN showed antidiarrheal effect (*p < 0.05), reducing the total stool amount (*55%, *48%, *44%, *24%) and diarrheal (*47%, *66%; *56%, 10%) respectively for the doses tested. All doses investigated in the enteropooling test presented significant changes (*46%, *78%, *66%, *41% respectively) in relation to the control. α-TPN through the muscarinic pathway reduced the gastrointestinal transit (*31%), besides inhibiting PGE2-induced diarrhea (*39%). α-TPN also reduced fluid formation and loss of Cl− ions, by interacting directly with GM1 receptors and cholera toxin, thus increasing the uptake of intestinal fluids. The results suggest an anti-diarrheal activity of α-TPN due to its anticholinergic action, ability to block PGE2 and GM1 receptors and interaction with cholera toxin in secretory diarrhea, making it a promising candidate drug for the treatment of diarrheal diseases.
We also recommend Trading Suppliers and Manufacturers of Terpineol (cas 8000-41-7). Pls Click Website Link as below: cas 8000-41-7 suppliers
Prev:Performance and emissions of gasoline blended with Terpineol (cas 8000-41-7) as an octane booster
Next:α-Terpineol (cas 8000-41-7) reduces cancer pain via modulation of oxidative stress and inhibition of iNOS) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Fragrance material review on Terpineol (cas 8000-41-7)07/21/2019
- α-Terpineol (cas 8000-41-7) and terpene-4-ol, the critical components of tea tree oil, exert antifungal activities in vitro and in vivo against Aspergillus niger in grapes by inducing morphous damage and metabolic changes of fungus07/19/2019
- Discovery of a novel series of α-Terpineol (cas 8000-41-7) derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation07/18/2019
- Terpineol (cas 8000-41-7) as a novel octane booster for extending the knock limit of gasoline07/17/2019
- α-Terpineol (cas 8000-41-7) reduces cancer pain via modulation of oxidative stress and inhibition of iNOS07/16/2019
- Performance and emissions of gasoline blended with Terpineol (cas 8000-41-7) as an octane booster07/14/2019
- Interfacial vibrational spectroscopy and Brewster angle microscopy distinguishing the interaction of Terpineol (cas 8000-41-7) in cell membrane models at the air-water interface07/13/2019
- Linalool- and α-Terpineol (cas 8000-41-7)-induced programmed cell death in Chlamydomonas reinhardtii07/12/2019


